Skip to content

Stanford Medicine's Jeffrey Goldberg believes a young, underexplored class of therapies called gliotherapeutics, which target and harness glia, will ultimately provide important new directions for treatment.

Stanford Medicine's Jeffrey Goldberg believes a young, underexplored class of therapies called gliotherapeutics, which target and harness glia, will ultimately provide important new directions for treatment.

Published on

By devising special pixels, Stanford University researchers have enhanced prosthetic vision with a new implant that improves vision.

By devising special pixels, Stanford University researchers have enhanced prosthetic vision with a new implant that improves vision.

Published on

In a clinical trial, a tiny prosthetic retinal device invented by a Stanford researcher has proved its potential ability to restore eyesight to the blind.

In a clinical trial, a tiny prosthetic retinal device invented by a Stanford researcher has proved its potential ability to restore eyesight to the blind.

Published on

This year, Stanford Biodesign Innovation Fellows will concentrate on ophthalmology, spending 10 months to address needs in that field.

This year, Stanford Biodesign Innovation Fellows will concentrate on ophthalmology, spending 10 months to address needs in that field.